Broadly neutralizing monoclonal antibodies (bNAbs)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Broadly neutralizing monoclonal antibodies (bNAbs), covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission [Phase 2]